nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0286	0.0562	CcSEcCtD
Indapamide—KCNE1—endocrine gland—polycystic ovary syndrome	0.0282	0.0914	CbGeAlD
Indapamide—Respiratory distress—Metformin—polycystic ovary syndrome	0.0237	0.0465	CcSEcCtD
Indapamide—Nail disorder—Metformin—polycystic ovary syndrome	0.0232	0.0455	CcSEcCtD
Indapamide—CA5A—endocrine gland—polycystic ovary syndrome	0.0214	0.0693	CbGeAlD
Indapamide—KCNQ1—adrenal cortex—polycystic ovary syndrome	0.0207	0.067	CbGeAlD
Indapamide—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0186	0.0365	CcSEcCtD
Indapamide—CYP3A4—urine—polycystic ovary syndrome	0.0184	0.0598	CbGeAlD
Indapamide—KCNQ1—pituitary gland—polycystic ovary syndrome	0.0167	0.0542	CbGeAlD
Indapamide—KCNQ1—adipose tissue—polycystic ovary syndrome	0.0166	0.0539	CbGeAlD
Indapamide—KCNQ1—adrenal gland—polycystic ovary syndrome	0.0149	0.0484	CbGeAlD
Indapamide—KCNQ1—female gonad—polycystic ovary syndrome	0.0139	0.0451	CbGeAlD
Indapamide—Lightheadedness—Metformin—polycystic ovary syndrome	0.0135	0.0264	CcSEcCtD
Indapamide—KCNQ1—endocrine gland—polycystic ovary syndrome	0.0129	0.042	CbGeAlD
Indapamide—Ear pain—Metformin—polycystic ovary syndrome	0.0128	0.0251	CcSEcCtD
Indapamide—CA9—endocrine gland—polycystic ovary syndrome	0.0125	0.0405	CbGeAlD
Indapamide—Lethargy—Metformin—polycystic ovary syndrome	0.0112	0.0219	CcSEcCtD
Indapamide—Migraine—Metformin—polycystic ovary syndrome	0.0108	0.0211	CcSEcCtD
Indapamide—CA5B—adipose tissue—polycystic ovary syndrome	0.0106	0.0345	CbGeAlD
Indapamide—Dehydration—Metformin—polycystic ovary syndrome	0.0102	0.0199	CcSEcCtD
Indapamide—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0101	0.0198	CcSEcCtD
Indapamide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00998	0.0196	CcSEcCtD
Indapamide—Cramp muscle—Metformin—polycystic ovary syndrome	0.00984	0.0193	CcSEcCtD
Indapamide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00977	0.0192	CcSEcCtD
Indapamide—CA5B—adrenal gland—polycystic ovary syndrome	0.00955	0.031	CbGeAlD
Indapamide—Influenza—Metformin—polycystic ovary syndrome	0.00945	0.0185	CcSEcCtD
Indapamide—Pancreatitis—Metformin—polycystic ovary syndrome	0.00926	0.0182	CcSEcCtD
Indapamide—CA2—embryo—polycystic ovary syndrome	0.00924	0.03	CbGeAlD
Indapamide—CA12—endocrine gland—polycystic ovary syndrome	0.00923	0.0299	CbGeAlD
Indapamide—Angina pectoris—Metformin—polycystic ovary syndrome	0.0092	0.0181	CcSEcCtD
Indapamide—CA5B—vagina—polycystic ovary syndrome	0.00885	0.0287	CbGeAlD
Indapamide—Drowsiness—Metformin—polycystic ovary syndrome	0.00842	0.0165	CcSEcCtD
Indapamide—CA5B—endocrine gland—polycystic ovary syndrome	0.00828	0.0268	CbGeAlD
Indapamide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00797	0.0156	CcSEcCtD
Indapamide—Rhinitis—Metformin—polycystic ovary syndrome	0.00758	0.0149	CcSEcCtD
Indapamide—CA2—adrenal cortex—polycystic ovary syndrome	0.00757	0.0245	CbGeAlD
Indapamide—Hepatitis—Metformin—polycystic ovary syndrome	0.00756	0.0148	CcSEcCtD
Indapamide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00752	0.0148	CcSEcCtD
Indapamide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00745	0.0146	CcSEcCtD
Indapamide—CA4—pituitary gland—polycystic ovary syndrome	0.00738	0.0239	CbGeAlD
Indapamide—CA4—adipose tissue—polycystic ovary syndrome	0.00735	0.0238	CbGeAlD
Indapamide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00702	0.0138	CcSEcCtD
Indapamide—Flushing—Metformin—polycystic ovary syndrome	0.00702	0.0138	CcSEcCtD
Indapamide—CA4—adrenal gland—polycystic ovary syndrome	0.00659	0.0214	CbGeAlD
Indapamide—Malnutrition—Metformin—polycystic ovary syndrome	0.00658	0.0129	CcSEcCtD
Indapamide—Erythema—Metformin—polycystic ovary syndrome	0.00658	0.0129	CcSEcCtD
Indapamide—Flatulence—Metformin—polycystic ovary syndrome	0.00649	0.0127	CcSEcCtD
Indapamide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00645	0.0126	CcSEcCtD
Indapamide—Muscle spasms—Metformin—polycystic ovary syndrome	0.00633	0.0124	CcSEcCtD
Indapamide—Vision blurred—Metformin—polycystic ovary syndrome	0.0062	0.0122	CcSEcCtD
Indapamide—CA4—female gonad—polycystic ovary syndrome	0.00615	0.0199	CbGeAlD
Indapamide—CA2—pituitary gland—polycystic ovary syndrome	0.00612	0.0198	CbGeAlD
Indapamide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00611	0.012	CcSEcCtD
Indapamide—CA2—adipose tissue—polycystic ovary syndrome	0.0061	0.0198	CbGeAlD
Indapamide—Malaise—Metformin—polycystic ovary syndrome	0.00594	0.0116	CcSEcCtD
Indapamide—Syncope—Metformin—polycystic ovary syndrome	0.0059	0.0116	CcSEcCtD
Indapamide—Palpitations—Metformin—polycystic ovary syndrome	0.00582	0.0114	CcSEcCtD
Indapamide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00578	0.0114	CcSEcCtD
Indapamide—CA4—endocrine gland—polycystic ovary syndrome	0.00572	0.0185	CbGeAlD
Indapamide—Myalgia—Metformin—polycystic ovary syndrome	0.0056	0.011	CcSEcCtD
Indapamide—Chest pain—Metformin—polycystic ovary syndrome	0.0056	0.011	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00556	0.0109	CcSEcCtD
Indapamide—Discomfort—Metformin—polycystic ovary syndrome	0.00554	0.0109	CcSEcCtD
Indapamide—CA2—adrenal gland—polycystic ovary syndrome	0.00547	0.0177	CbGeAlD
Indapamide—Oedema—Metformin—polycystic ovary syndrome	0.00537	0.0105	CcSEcCtD
Indapamide—Infection—Metformin—polycystic ovary syndrome	0.00534	0.0105	CcSEcCtD
Indapamide—Shock—Metformin—polycystic ovary syndrome	0.00528	0.0104	CcSEcCtD
Indapamide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00527	0.0103	CcSEcCtD
Indapamide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00526	0.0103	CcSEcCtD
Indapamide—Skin disorder—Metformin—polycystic ovary syndrome	0.00522	0.0102	CcSEcCtD
Indapamide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00519	0.0102	CcSEcCtD
Indapamide—Anorexia—Metformin—polycystic ovary syndrome	0.00512	0.01	CcSEcCtD
Indapamide—CA2—female gonad—polycystic ovary syndrome	0.0051	0.0165	CbGeAlD
Indapamide—CA2—vagina—polycystic ovary syndrome	0.00507	0.0164	CbGeAlD
Indapamide—Hypotension—Metformin—polycystic ovary syndrome	0.00502	0.00985	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00489	0.0096	CcSEcCtD
Indapamide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00482	0.00946	CcSEcCtD
Indapamide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00479	0.0094	CcSEcCtD
Indapamide—Somnolence—Metformin—polycystic ovary syndrome	0.00478	0.00937	CcSEcCtD
Indapamide—CA2—endocrine gland—polycystic ovary syndrome	0.00474	0.0154	CbGeAlD
Indapamide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00473	0.00928	CcSEcCtD
Indapamide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00467	0.00916	CcSEcCtD
Indapamide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00464	0.0091	CcSEcCtD
Indapamide—Fatigue—Metformin—polycystic ovary syndrome	0.00463	0.00909	CcSEcCtD
Indapamide—Constipation—Metformin—polycystic ovary syndrome	0.00459	0.00901	CcSEcCtD
Indapamide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00443	0.00869	CcSEcCtD
Indapamide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00439	0.00862	CcSEcCtD
Indapamide—Urticaria—Metformin—polycystic ovary syndrome	0.00427	0.00837	CcSEcCtD
Indapamide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00425	0.00833	CcSEcCtD
Indapamide—Asthenia—Metformin—polycystic ovary syndrome	0.00385	0.00756	CcSEcCtD
Indapamide—Pruritus—Metformin—polycystic ovary syndrome	0.0038	0.00746	CcSEcCtD
Indapamide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00368	0.00721	CcSEcCtD
Indapamide—Dizziness—Metformin—polycystic ovary syndrome	0.00355	0.00697	CcSEcCtD
Indapamide—Vomiting—Metformin—polycystic ovary syndrome	0.00342	0.0067	CcSEcCtD
Indapamide—Rash—Metformin—polycystic ovary syndrome	0.00339	0.00665	CcSEcCtD
Indapamide—Dermatitis—Metformin—polycystic ovary syndrome	0.00338	0.00664	CcSEcCtD
Indapamide—Headache—Metformin—polycystic ovary syndrome	0.00337	0.0066	CcSEcCtD
Indapamide—Nausea—Metformin—polycystic ovary syndrome	0.00319	0.00626	CcSEcCtD
Indapamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00306	0.00991	CbGeAlD
Indapamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000594	0.00327	CbGpPWpGaD
Indapamide—CA5A—Metabolism—STAR—polycystic ovary syndrome	0.00059	0.00325	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SRD5A1—polycystic ovary syndrome	0.000578	0.00318	CbGpPWpGaD
Indapamide—CA7—Metabolism—SRD5A1—polycystic ovary syndrome	0.000578	0.00318	CbGpPWpGaD
Indapamide—CA12—Metabolism—PNPLA2—polycystic ovary syndrome	0.000565	0.00311	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000555	0.00305	CbGpPWpGaD
Indapamide—CA7—Metabolism—STAR—polycystic ovary syndrome	0.000551	0.00303	CbGpPWpGaD
Indapamide—CA5B—Metabolism—STAR—polycystic ovary syndrome	0.000551	0.00303	CbGpPWpGaD
Indapamide—CA9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000549	0.00302	CbGpPWpGaD
Indapamide—CA9—Metabolism—SUOX—polycystic ovary syndrome	0.000549	0.00302	CbGpPWpGaD
Indapamide—CA4—Metabolism—TEAD2—polycystic ovary syndrome	0.000537	0.00296	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000537	0.00296	CbGpPWpGaD
Indapamide—CA12—Metabolism—SRD5A1—polycystic ovary syndrome	0.000535	0.00294	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HMMR—polycystic ovary syndrome	0.000526	0.00289	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000518	0.00285	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000516	0.00284	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000515	0.00283	CbGpPWpGaD
Indapamide—CA2—Metabolism—TEAD2—polycystic ovary syndrome	0.000515	0.00283	CbGpPWpGaD
Indapamide—CA9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000511	0.00281	CbGpPWpGaD
Indapamide—CA12—Metabolism—STAR—polycystic ovary syndrome	0.000511	0.00281	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HSD3B1—polycystic ovary syndrome	0.000502	0.00276	CbGpPWpGaD
Indapamide—CA7—Metabolism—HMMR—polycystic ovary syndrome	0.000491	0.0027	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HMMR—polycystic ovary syndrome	0.000491	0.0027	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000472	0.0026	CbGpPWpGaD
Indapamide—CA7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000469	0.00258	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HSD3B1—polycystic ovary syndrome	0.000469	0.00258	CbGpPWpGaD
Indapamide—CA5A—Metabolism—LHB—polycystic ovary syndrome	0.000458	0.00252	CbGpPWpGaD
Indapamide—CA12—Metabolism—HMMR—polycystic ovary syndrome	0.000455	0.0025	CbGpPWpGaD
Indapamide—CA4—Metabolism—PNPLA2—polycystic ovary syndrome	0.00045	0.00248	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00045	0.00248	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HSD3B2—polycystic ovary syndrome	0.000447	0.00246	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000444	0.00244	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000434	0.00239	CbGpPWpGaD
Indapamide—CA12—Metabolism—HSD3B1—polycystic ovary syndrome	0.000434	0.00239	CbGpPWpGaD
Indapamide—CA9—Metabolism—TEAD2—polycystic ovary syndrome	0.000434	0.00239	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKR1C1—polycystic ovary syndrome	0.000433	0.00238	CbGpPWpGaD
Indapamide—CA2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000432	0.00237	CbGpPWpGaD
Indapamide—CA7—Metabolism—LHB—polycystic ovary syndrome	0.000427	0.00235	CbGpPWpGaD
Indapamide—CA5B—Metabolism—LHB—polycystic ovary syndrome	0.000427	0.00235	CbGpPWpGaD
Indapamide—CA4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000427	0.00235	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000422	0.00232	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000418	0.0023	CbGpPWpGaD
Indapamide—CA7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000418	0.0023	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HSD3B2—polycystic ovary syndrome	0.000418	0.0023	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000413	0.00227	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00041	0.00225	CbGpPWpGaD
Indapamide—CA2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000409	0.00225	CbGpPWpGaD
Indapamide—CA4—Metabolism—STAR—polycystic ovary syndrome	0.000407	0.00224	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKR1C1—polycystic ovary syndrome	0.000405	0.00223	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000405	0.00223	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SULT2A1—polycystic ovary syndrome	0.000399	0.00219	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000396	0.00218	CbGpPWpGaD
Indapamide—CA12—Metabolism—LHB—polycystic ovary syndrome	0.000396	0.00218	CbGpPWpGaD
Indapamide—CA2—Metabolism—STAR—polycystic ovary syndrome	0.00039	0.00215	CbGpPWpGaD
Indapamide—CA12—Metabolism—HSD3B2—polycystic ovary syndrome	0.000387	0.00213	CbGpPWpGaD
Indapamide—CA5A—Metabolism—RRM2—polycystic ovary syndrome	0.000386	0.00212	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKR1C1—polycystic ovary syndrome	0.000375	0.00206	CbGpPWpGaD
Indapamide—CA5A—Metabolism—YAP1—polycystic ovary syndrome	0.000372	0.00205	CbGpPWpGaD
Indapamide—CA7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000372	0.00205	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SULT2A1—polycystic ovary syndrome	0.000372	0.00205	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000365	0.00201	CbGpPWpGaD
Indapamide—CA9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000364	0.002	CbGpPWpGaD
Indapamide—CA4—Metabolism—HMMR—polycystic ovary syndrome	0.000363	0.002	CbGpPWpGaD
Indapamide—CA5B—Metabolism—RRM2—polycystic ovary syndrome	0.000361	0.00198	CbGpPWpGaD
Indapamide—CA7—Metabolism—RRM2—polycystic ovary syndrome	0.000361	0.00198	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NAMPT—polycystic ovary syndrome	0.000358	0.00197	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000353	0.00194	CbGpPWpGaD
Indapamide—CA2—Metabolism—HMMR—polycystic ovary syndrome	0.000348	0.00191	CbGpPWpGaD
Indapamide—CA5B—Metabolism—YAP1—polycystic ovary syndrome	0.000348	0.00191	CbGpPWpGaD
Indapamide—CA7—Metabolism—YAP1—polycystic ovary syndrome	0.000348	0.00191	CbGpPWpGaD
Indapamide—CA4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000346	0.0019	CbGpPWpGaD
Indapamide—CA12—Metabolism—SULT2A1—polycystic ovary syndrome	0.000345	0.0019	CbGpPWpGaD
Indapamide—CA9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000345	0.0019	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000339	0.00187	CbGpPWpGaD
Indapamide—CA12—Metabolism—RRM2—polycystic ovary syndrome	0.000334	0.00184	CbGpPWpGaD
Indapamide—CA7—Metabolism—NAMPT—polycystic ovary syndrome	0.000334	0.00184	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NAMPT—polycystic ovary syndrome	0.000334	0.00184	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKR1C3—polycystic ovary syndrome	0.000334	0.00183	CbGpPWpGaD
Indapamide—CA2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000332	0.00183	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000331	0.00182	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00033	0.00182	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP11A1—polycystic ovary syndrome	0.00033	0.00181	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP11A1—polycystic ovary syndrome	0.00033	0.00181	CbGpPWpGaD
Indapamide—CA9—Metabolism—STAR—polycystic ovary syndrome	0.000329	0.00181	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000328	0.00181	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000327	0.0018	CbGpPWpGaD
Indapamide—CA12—Metabolism—YAP1—polycystic ovary syndrome	0.000322	0.00177	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000318	0.00175	CbGpPWpGaD
Indapamide—CA4—Metabolism—LHB—polycystic ovary syndrome	0.000316	0.00174	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000311	0.00171	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKR1C3—polycystic ovary syndrome	0.000311	0.00171	CbGpPWpGaD
Indapamide—CA12—Metabolism—NAMPT—polycystic ovary syndrome	0.000309	0.0017	CbGpPWpGaD
Indapamide—CA4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000309	0.0017	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP17A1—polycystic ovary syndrome	0.000307	0.00169	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000307	0.00169	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP11A1—polycystic ovary syndrome	0.000306	0.00168	CbGpPWpGaD
Indapamide—CA2—Metabolism—LHB—polycystic ovary syndrome	0.000303	0.00167	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000299	0.00164	CbGpPWpGaD
Indapamide—CA2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000296	0.00163	CbGpPWpGaD
Indapamide—CA9—Metabolism—HMMR—polycystic ovary syndrome	0.000293	0.00161	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKR1C3—polycystic ovary syndrome	0.000289	0.00159	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000287	0.00158	CbGpPWpGaD
Indapamide—CA5A—Metabolism—TH—polycystic ovary syndrome	0.000284	0.00156	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP17A1—polycystic ovary syndrome	0.000284	0.00156	CbGpPWpGaD
Indapamide—CA9—Metabolism—HSD3B1—polycystic ovary syndrome	0.00028	0.00154	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SLC2A4—polycystic ovary syndrome	0.000276	0.00152	CbGpPWpGaD
Indapamide—CA4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000275	0.00151	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000268	0.00148	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000267	0.00147	CbGpPWpGaD
Indapamide—CA4—Metabolism—RRM2—polycystic ovary syndrome	0.000266	0.00147	CbGpPWpGaD
Indapamide—CA7—Metabolism—TH—polycystic ovary syndrome	0.000265	0.00146	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TH—polycystic ovary syndrome	0.000265	0.00146	CbGpPWpGaD
Indapamide—CA2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000264	0.00145	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000263	0.00145	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP19A1—polycystic ovary syndrome	0.00026	0.00143	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC2A4—polycystic ovary syndrome	0.000258	0.00142	CbGpPWpGaD
Indapamide—CA7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000258	0.00142	CbGpPWpGaD
Indapamide—CA4—Metabolism—YAP1—polycystic ovary syndrome	0.000257	0.00141	CbGpPWpGaD
Indapamide—CA2—Metabolism—RRM2—polycystic ovary syndrome	0.000255	0.0014	CbGpPWpGaD
Indapamide—CA9—Metabolism—LHB—polycystic ovary syndrome	0.000255	0.0014	CbGpPWpGaD
Indapamide—CA9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000249	0.00137	CbGpPWpGaD
Indapamide—CA4—Metabolism—NAMPT—polycystic ovary syndrome	0.000247	0.00136	CbGpPWpGaD
Indapamide—CA2—Metabolism—YAP1—polycystic ovary syndrome	0.000246	0.00135	CbGpPWpGaD
Indapamide—CA12—Metabolism—TH—polycystic ovary syndrome	0.000246	0.00135	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000244	0.00134	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP19A1—polycystic ovary syndrome	0.000243	0.00133	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000243	0.00133	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000242	0.00133	CbGpPWpGaD
Indapamide—CA12—Metabolism—SLC2A4—polycystic ovary syndrome	0.000239	0.00132	CbGpPWpGaD
Indapamide—CA2—Metabolism—NAMPT—polycystic ovary syndrome	0.000237	0.0013	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000235	0.00129	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000234	0.00128	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GNAS—polycystic ovary syndrome	0.000232	0.00128	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKR1C3—polycystic ovary syndrome	0.00023	0.00127	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000227	0.00125	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000227	0.00125	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	0.000225	0.00124	CbGpPWpGaD
Indapamide—CA9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000222	0.00122	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NCOR1—polycystic ovary syndrome	0.000221	0.00122	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000221	0.00121	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000219	0.0012	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000217	0.00119	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GNAS—polycystic ovary syndrome	0.000217	0.00119	CbGpPWpGaD
Indapamide—CA7—Metabolism—GNAS—polycystic ovary syndrome	0.000217	0.00119	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000216	0.00119	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000216	0.00119	CbGpPWpGaD
Indapamide—CA9—Metabolism—RRM2—polycystic ovary syndrome	0.000215	0.00118	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP1A1—polycystic ovary syndrome	0.00021	0.00115	CbGpPWpGaD
Indapamide—CA9—Metabolism—YAP1—polycystic ovary syndrome	0.000208	0.00114	CbGpPWpGaD
Indapamide—CA7—Metabolism—NCOR1—polycystic ovary syndrome	0.000206	0.00113	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NCOR1—polycystic ovary syndrome	0.000206	0.00113	CbGpPWpGaD
Indapamide—CA12—Metabolism—GNAS—polycystic ovary syndrome	0.000201	0.0011	CbGpPWpGaD
Indapamide—CA9—Metabolism—NAMPT—polycystic ovary syndrome	0.000199	0.0011	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000199	0.00109	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000197	0.00108	CbGpPWpGaD
Indapamide—CA4—Metabolism—TH—polycystic ovary syndrome	0.000196	0.00108	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	0.000196	0.00108	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000196	0.00108	CbGpPWpGaD
Indapamide—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	0.000195	0.00107	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000194	0.00107	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000191	0.00105	CbGpPWpGaD
Indapamide—CA12—Metabolism—NCOR1—polycystic ovary syndrome	0.000191	0.00105	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000191	0.00105	CbGpPWpGaD
Indapamide—CA2—Metabolism—TH—polycystic ovary syndrome	0.000188	0.00103	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000186	0.00102	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000183	0.00101	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000183	0.00101	CbGpPWpGaD
Indapamide—CA7—Metabolism—MTHFR—polycystic ovary syndrome	0.000182	0.001	CbGpPWpGaD
Indapamide—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	0.000182	0.001	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	0.000181	0.000997	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000181	0.000993	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00018	0.000991	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000179	0.000986	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000178	0.000977	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000172	0.000945	CbGpPWpGaD
Indapamide—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000169	0.000929	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000161	0.000887	CbGpPWpGaD
Indapamide—CA4—Metabolism—GNAS—polycystic ovary syndrome	0.00016	0.00088	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PPARG—polycystic ovary syndrome	0.000158	0.000871	CbGpPWpGaD
Indapamide—CA9—Metabolism—TH—polycystic ovary syndrome	0.000158	0.000871	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000157	0.000864	CbGpPWpGaD
Indapamide—CA5A—Metabolism—POMC—polycystic ovary syndrome	0.000156	0.000859	CbGpPWpGaD
Indapamide—CA5A—Metabolism—INS—polycystic ovary syndrome	0.000155	0.000854	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000154	0.000847	CbGpPWpGaD
Indapamide—CA2—Metabolism—GNAS—polycystic ovary syndrome	0.000153	0.000844	CbGpPWpGaD
Indapamide—CA4—Metabolism—NCOR1—polycystic ovary syndrome	0.000152	0.000838	CbGpPWpGaD
Indapamide—CA7—Metabolism—PPARG—polycystic ovary syndrome	0.000148	0.000813	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PPARG—polycystic ovary syndrome	0.000148	0.000813	CbGpPWpGaD
Indapamide—CA2—Metabolism—NCOR1—polycystic ovary syndrome	0.000146	0.000804	CbGpPWpGaD
Indapamide—CA7—Metabolism—POMC—polycystic ovary syndrome	0.000146	0.000802	CbGpPWpGaD
Indapamide—CA5B—Metabolism—POMC—polycystic ovary syndrome	0.000146	0.000802	CbGpPWpGaD
Indapamide—CA5B—Metabolism—INS—polycystic ovary syndrome	0.000145	0.000798	CbGpPWpGaD
Indapamide—CA7—Metabolism—INS—polycystic ovary syndrome	0.000145	0.000798	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000145	0.000797	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000145	0.000795	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000143	0.000784	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000141	0.000774	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000139	0.000762	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000137	0.000753	CbGpPWpGaD
Indapamide—CA12—Metabolism—POMC—polycystic ovary syndrome	0.000135	0.000743	CbGpPWpGaD
Indapamide—CA4—Metabolism—MTHFR—polycystic ovary syndrome	0.000135	0.000741	CbGpPWpGaD
Indapamide—CA12—Metabolism—INS—polycystic ovary syndrome	0.000134	0.000739	CbGpPWpGaD
Indapamide—CA9—Metabolism—GNAS—polycystic ovary syndrome	0.000129	0.000711	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTHFR—polycystic ovary syndrome	0.000129	0.00071	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOR1—polycystic ovary syndrome	0.000123	0.000677	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000117	0.000642	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000115	0.000632	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000113	0.000624	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARG—polycystic ovary syndrome	0.000109	0.000601	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTHFR—polycystic ovary syndrome	0.000109	0.000599	CbGpPWpGaD
Indapamide—CA4—Metabolism—POMC—polycystic ovary syndrome	0.000108	0.000593	CbGpPWpGaD
Indapamide—CA4—Metabolism—INS—polycystic ovary syndrome	0.000107	0.000589	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARG—polycystic ovary syndrome	0.000105	0.000576	CbGpPWpGaD
Indapamide—CA2—Metabolism—POMC—polycystic ovary syndrome	0.000103	0.000568	CbGpPWpGaD
Indapamide—CA2—Metabolism—INS—polycystic ovary syndrome	0.000103	0.000565	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000101	0.000556	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.25e-05	0.000509	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.25e-05	0.000509	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARG—polycystic ovary syndrome	8.83e-05	0.000486	CbGpPWpGaD
Indapamide—CA9—Metabolism—POMC—polycystic ovary syndrome	8.71e-05	0.000479	CbGpPWpGaD
Indapamide—CA9—Metabolism—INS—polycystic ovary syndrome	8.66e-05	0.000476	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	8.6e-05	0.000473	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	8.57e-05	0.000471	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.31e-05	0.000402	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.31e-05	0.000402	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.13e-05	0.000337	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.81e-05	0.000319	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.54e-05	0.000305	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.94e-05	0.000272	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.71e-05	0.000259	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.3e-05	0.000236	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.2e-05	0.000231	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.07e-05	0.000224	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.74e-05	0.000206	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.62e-05	0.000199	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.49e-05	0.000192	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.36e-05	0.000185	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.31e-05	0.000182	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.13e-05	0.000172	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.08e-05	0.000169	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.67e-05	0.000147	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.59e-05	0.000143	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.44e-05	0.000134	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.18e-05	0.00012	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.07e-05	0.000114	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.97e-05	0.000108	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.83e-05	0.000101	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.49e-05	8.17e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.47e-05	8.06e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.46e-05	8.02e-05	CbGpPWpGaD
